nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofazimine—ABCB1—Lisinopril—systemic scleroderma	0.185	0.272	CbGbCtD
Clofazimine—ABCB1—Captopril—systemic scleroderma	0.138	0.203	CbGbCtD
Clofazimine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.109	0.16	CbGbCtD
Clofazimine—ABCB1—Prednisone—systemic scleroderma	0.0871	0.128	CbGbCtD
Clofazimine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0653	0.0959	CbGbCtD
Clofazimine—CYP3A4—Prednisone—systemic scleroderma	0.0522	0.0767	CbGbCtD
Clofazimine—ABCB1—Methotrexate—systemic scleroderma	0.0437	0.0642	CbGbCtD
Clofazimine—Acneiform eruption—Mometasone—systemic scleroderma	0.0165	0.0517	CcSEcCtD
Clofazimine—Dermatitis acneiform—Mometasone—systemic scleroderma	0.0122	0.0383	CcSEcCtD
Clofazimine—Enteritis—Mycophenolate mofetil—systemic scleroderma	0.00666	0.0209	CcSEcCtD
Clofazimine—Acneiform eruption—Prednisone—systemic scleroderma	0.00611	0.0191	CcSEcCtD
Clofazimine—Thromboembolism—Prednisone—systemic scleroderma	0.00485	0.0152	CcSEcCtD
Clofazimine—Skin discolouration—Mometasone—systemic scleroderma	0.00463	0.0145	CcSEcCtD
Clofazimine—Dermatitis acneiform—Prednisone—systemic scleroderma	0.00452	0.0141	CcSEcCtD
Clofazimine—Neuralgia—Leflunomide—systemic scleroderma	0.00435	0.0136	CcSEcCtD
Clofazimine—Enteritis—Methotrexate—systemic scleroderma	0.00378	0.0118	CcSEcCtD
Clofazimine—Skin discolouration—Leflunomide—systemic scleroderma	0.00335	0.0105	CcSEcCtD
Clofazimine—Bone pain—Leflunomide—systemic scleroderma	0.00316	0.00988	CcSEcCtD
Clofazimine—Lymphadenopathy—Captopril—systemic scleroderma	0.00312	0.00977	CcSEcCtD
Clofazimine—Embolism venous—Prednisone—systemic scleroderma	0.00306	0.00957	CcSEcCtD
Clofazimine—Cystitis noninfective—Leflunomide—systemic scleroderma	0.00295	0.00924	CcSEcCtD
Clofazimine—Cystitis—Leflunomide—systemic scleroderma	0.00292	0.00914	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Captopril—systemic scleroderma	0.00282	0.00883	CcSEcCtD
Clofazimine—Bladder pain—Leflunomide—systemic scleroderma	0.00273	0.00856	CcSEcCtD
Clofazimine—Drowsiness—Pentoxifylline—systemic scleroderma	0.00271	0.00847	CcSEcCtD
Clofazimine—Jaundice—Pentoxifylline—systemic scleroderma	0.00264	0.00826	CcSEcCtD
Clofazimine—Bladder pain—Mycophenolic acid—systemic scleroderma	0.00261	0.00816	CcSEcCtD
Clofazimine—Lymphadenopathy—Leflunomide—systemic scleroderma	0.00257	0.00805	CcSEcCtD
Clofazimine—Cystitis noninfective—Lisinopril—systemic scleroderma	0.00254	0.00794	CcSEcCtD
Clofazimine—Skin discolouration—Mycophenolate mofetil—systemic scleroderma	0.00252	0.00789	CcSEcCtD
Clofazimine—Cystitis—Lisinopril—systemic scleroderma	0.00251	0.00785	CcSEcCtD
Clofazimine—Lymphadenopathy—Mycophenolic acid—systemic scleroderma	0.00245	0.00768	CcSEcCtD
Clofazimine—Hepatitis—Pentoxifylline—systemic scleroderma	0.00243	0.00761	CcSEcCtD
Clofazimine—Embolism—Prednisone—systemic scleroderma	0.0024	0.00752	CcSEcCtD
Clofazimine—Bone pain—Mycophenolate mofetil—systemic scleroderma	0.00238	0.00744	CcSEcCtD
Clofazimine—Bladder pain—Lisinopril—systemic scleroderma	0.00235	0.00735	CcSEcCtD
Clofazimine—Eosinophilia—Captopril—systemic scleroderma	0.00228	0.00713	CcSEcCtD
Clofazimine—Cystitis noninfective—Mycophenolate mofetil—systemic scleroderma	0.00222	0.00696	CcSEcCtD
Clofazimine—Cystitis—Mycophenolate mofetil—systemic scleroderma	0.0022	0.00688	CcSEcCtD
Clofazimine—Hepatomegaly—Prednisone—systemic scleroderma	0.00218	0.00682	CcSEcCtD
Clofazimine—Photosensitivity reaction—Captopril—systemic scleroderma	0.0021	0.00657	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Mycophenolic acid—systemic scleroderma	0.00209	0.00655	CcSEcCtD
Clofazimine—Weight decreased—Captopril—systemic scleroderma	0.00208	0.00652	CcSEcCtD
Clofazimine—Bladder pain—Mycophenolate mofetil—systemic scleroderma	0.00206	0.00644	CcSEcCtD
Clofazimine—Embolism—Methotrexate—systemic scleroderma	0.00201	0.00629	CcSEcCtD
Clofazimine—Jaundice—Captopril—systemic scleroderma	0.002	0.00626	CcSEcCtD
Clofazimine—Hypokalaemia—Leflunomide—systemic scleroderma	0.002	0.00625	CcSEcCtD
Clofazimine—Anaemia—Pentoxifylline—systemic scleroderma	0.00196	0.00612	CcSEcCtD
Clofazimine—Lymphadenopathy—Mycophenolate mofetil—systemic scleroderma	0.00194	0.00606	CcSEcCtD
Clofazimine—Abdominal pain upper—Mycophenolic acid—systemic scleroderma	0.00191	0.00598	CcSEcCtD
Clofazimine—Hypokalaemia—Mycophenolic acid—systemic scleroderma	0.00191	0.00596	CcSEcCtD
Clofazimine—Eosinophilia—Leflunomide—systemic scleroderma	0.00188	0.00588	CcSEcCtD
Clofazimine—Hepatitis—Captopril—systemic scleroderma	0.00184	0.00577	CcSEcCtD
Clofazimine—Oedema—Pentoxifylline—systemic scleroderma	0.00173	0.0054	CcSEcCtD
Clofazimine—Weight decreased—Leflunomide—systemic scleroderma	0.00172	0.00537	CcSEcCtD
Clofazimine—Hyperglycaemia—Leflunomide—systemic scleroderma	0.00171	0.00536	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.00165	0.00517	CcSEcCtD
Clofazimine—Jaundice—Leflunomide—systemic scleroderma	0.00165	0.00516	CcSEcCtD
Clofazimine—Anorexia—Pentoxifylline—systemic scleroderma	0.00165	0.00515	CcSEcCtD
Clofazimine—Weight decreased—Mycophenolic acid—systemic scleroderma	0.00164	0.00512	CcSEcCtD
Clofazimine—Hyperglycaemia—Mycophenolic acid—systemic scleroderma	0.00163	0.00511	CcSEcCtD
Clofazimine—Eosinophilia—Lisinopril—systemic scleroderma	0.00161	0.00505	CcSEcCtD
Clofazimine—Jaundice—Mycophenolic acid—systemic scleroderma	0.00157	0.00492	CcSEcCtD
Clofazimine—Somnolence—Pentoxifylline—systemic scleroderma	0.00154	0.00481	CcSEcCtD
Clofazimine—Hepatitis—Leflunomide—systemic scleroderma	0.00152	0.00475	CcSEcCtD
Clofazimine—Hypokalaemia—Mycophenolate mofetil—systemic scleroderma	0.0015	0.00471	CcSEcCtD
Clofazimine—Decreased appetite—Pentoxifylline—systemic scleroderma	0.0015	0.0047	CcSEcCtD
Clofazimine—Photosensitivity reaction—Lisinopril—systemic scleroderma	0.00149	0.00466	CcSEcCtD
Clofazimine—Anaemia—Captopril—systemic scleroderma	0.00148	0.00464	CcSEcCtD
Clofazimine—Constipation—Pentoxifylline—systemic scleroderma	0.00148	0.00462	CcSEcCtD
Clofazimine—Weight decreased—Lisinopril—systemic scleroderma	0.00148	0.00462	CcSEcCtD
Clofazimine—Hyperglycaemia—Lisinopril—systemic scleroderma	0.00147	0.0046	CcSEcCtD
Clofazimine—Depression—Lisinopril—systemic scleroderma	0.00145	0.00454	CcSEcCtD
Clofazimine—Hepatitis—Mycophenolic acid—systemic scleroderma	0.00145	0.00453	CcSEcCtD
Clofazimine—Skin discolouration—Methotrexate—systemic scleroderma	0.00143	0.00447	CcSEcCtD
Clofazimine—Anorexia—Mometasone—systemic scleroderma	0.00142	0.00445	CcSEcCtD
Clofazimine—Jaundice—Lisinopril—systemic scleroderma	0.00142	0.00443	CcSEcCtD
Clofazimine—Visual impairment—Mycophenolic acid—systemic scleroderma	0.0014	0.00437	CcSEcCtD
Clofazimine—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00137	0.00427	CcSEcCtD
Clofazimine—Hepatitis—Lisinopril—systemic scleroderma	0.00131	0.00408	CcSEcCtD
Clofazimine—Decreased appetite—Mometasone—systemic scleroderma	0.0013	0.00405	CcSEcCtD
Clofazimine—Anaemia—Azathioprine—systemic scleroderma	0.00129	0.00405	CcSEcCtD
Clofazimine—Weight decreased—Mycophenolate mofetil—systemic scleroderma	0.00129	0.00404	CcSEcCtD
Clofazimine—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.00129	0.00403	CcSEcCtD
Clofazimine—Fatigue—Mometasone—systemic scleroderma	0.00129	0.00402	CcSEcCtD
Clofazimine—Depression—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00397	CcSEcCtD
Clofazimine—Cystitis noninfective—Methotrexate—systemic scleroderma	0.00126	0.00394	CcSEcCtD
Clofazimine—Anorexia—Captopril—systemic scleroderma	0.00125	0.0039	CcSEcCtD
Clofazimine—Cystitis—Methotrexate—systemic scleroderma	0.00125	0.0039	CcSEcCtD
Clofazimine—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00388	CcSEcCtD
Clofazimine—Asthenia—Pentoxifylline—systemic scleroderma	0.00124	0.00388	CcSEcCtD
Clofazimine—Pruritus—Pentoxifylline—systemic scleroderma	0.00122	0.00382	CcSEcCtD
Clofazimine—Anaemia—Leflunomide—systemic scleroderma	0.00122	0.00382	CcSEcCtD
Clofazimine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00118	0.0037	CcSEcCtD
Clofazimine—Body temperature increased—Mometasone—systemic scleroderma	0.00118	0.00369	CcSEcCtD
Clofazimine—Bladder pain—Methotrexate—systemic scleroderma	0.00117	0.00365	CcSEcCtD
Clofazimine—Anaemia—Mycophenolic acid—systemic scleroderma	0.00117	0.00365	CcSEcCtD
Clofazimine—Somnolence—Captopril—systemic scleroderma	0.00116	0.00364	CcSEcCtD
Clofazimine—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00358	CcSEcCtD
Clofazimine—Dizziness—Pentoxifylline—systemic scleroderma	0.00114	0.00357	CcSEcCtD
Clofazimine—Decreased appetite—Captopril—systemic scleroderma	0.00114	0.00356	CcSEcCtD
Clofazimine—Fatigue—Captopril—systemic scleroderma	0.00113	0.00353	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Prednisone—systemic scleroderma	0.00112	0.00351	CcSEcCtD
Clofazimine—Constipation—Captopril—systemic scleroderma	0.00112	0.0035	CcSEcCtD
Clofazimine—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.0011	0.00345	CcSEcCtD
Clofazimine—Vomiting—Pentoxifylline—systemic scleroderma	0.0011	0.00344	CcSEcCtD
Clofazimine—Lymphadenopathy—Methotrexate—systemic scleroderma	0.0011	0.00343	CcSEcCtD
Clofazimine—Rash—Pentoxifylline—systemic scleroderma	0.00109	0.00341	CcSEcCtD
Clofazimine—Dermatitis—Pentoxifylline—systemic scleroderma	0.00109	0.0034	CcSEcCtD
Clofazimine—Headache—Pentoxifylline—systemic scleroderma	0.00108	0.00339	CcSEcCtD
Clofazimine—Asthenia—Mometasone—systemic scleroderma	0.00107	0.00335	CcSEcCtD
Clofazimine—Pruritus—Mometasone—systemic scleroderma	0.00105	0.0033	CcSEcCtD
Clofazimine—Anaemia—Lisinopril—systemic scleroderma	0.00105	0.00329	CcSEcCtD
Clofazimine—Body temperature increased—Captopril—systemic scleroderma	0.00103	0.00324	CcSEcCtD
Clofazimine—Oedema—Mycophenolic acid—systemic scleroderma	0.00103	0.00322	CcSEcCtD
Clofazimine—Anorexia—Leflunomide—systemic scleroderma	0.00103	0.00322	CcSEcCtD
Clofazimine—Nausea—Pentoxifylline—systemic scleroderma	0.00103	0.00321	CcSEcCtD
Clofazimine—Diarrhoea—Mometasone—systemic scleroderma	0.00102	0.00319	CcSEcCtD
Clofazimine—Hypokalaemia—Prednisone—systemic scleroderma	0.00102	0.00319	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.000992	0.0031	CcSEcCtD
Clofazimine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000981	0.00307	CcSEcCtD
Clofazimine—Vomiting—Mometasone—systemic scleroderma	0.000948	0.00297	CcSEcCtD
Clofazimine—Rash—Mometasone—systemic scleroderma	0.00094	0.00294	CcSEcCtD
Clofazimine—Asthenia—Captopril—systemic scleroderma	0.000939	0.00294	CcSEcCtD
Clofazimine—Dermatitis—Mometasone—systemic scleroderma	0.000939	0.00294	CcSEcCtD
Clofazimine—Decreased appetite—Leflunomide—systemic scleroderma	0.000938	0.00293	CcSEcCtD
Clofazimine—Headache—Mometasone—systemic scleroderma	0.000934	0.00292	CcSEcCtD
Clofazimine—Fatigue—Leflunomide—systemic scleroderma	0.00093	0.00291	CcSEcCtD
Clofazimine—Oedema—Lisinopril—systemic scleroderma	0.000927	0.0029	CcSEcCtD
Clofazimine—Pruritus—Captopril—systemic scleroderma	0.000926	0.0029	CcSEcCtD
Clofazimine—Constipation—Leflunomide—systemic scleroderma	0.000923	0.00289	CcSEcCtD
Clofazimine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00092	0.00288	CcSEcCtD
Clofazimine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000915	0.00286	CcSEcCtD
Clofazimine—Body temperature increased—Azathioprine—systemic scleroderma	0.000903	0.00283	CcSEcCtD
Clofazimine—Diarrhoea—Captopril—systemic scleroderma	0.000896	0.0028	CcSEcCtD
Clofazimine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000895	0.0028	CcSEcCtD
Clofazimine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000887	0.00278	CcSEcCtD
Clofazimine—Nausea—Mometasone—systemic scleroderma	0.000885	0.00277	CcSEcCtD
Clofazimine—Anorexia—Lisinopril—systemic scleroderma	0.000884	0.00277	CcSEcCtD
Clofazimine—Constipation—Mycophenolic acid—systemic scleroderma	0.00088	0.00275	CcSEcCtD
Clofazimine—Weight decreased—Prednisone—systemic scleroderma	0.000876	0.00274	CcSEcCtD
Clofazimine—Hyperglycaemia—Prednisone—systemic scleroderma	0.000873	0.00273	CcSEcCtD
Clofazimine—Dizziness—Captopril—systemic scleroderma	0.000866	0.00271	CcSEcCtD
Clofazimine—Depression—Prednisone—systemic scleroderma	0.000861	0.00269	CcSEcCtD
Clofazimine—Body temperature increased—Leflunomide—systemic scleroderma	0.000853	0.00267	CcSEcCtD
Clofazimine—Vomiting—Captopril—systemic scleroderma	0.000832	0.0026	CcSEcCtD
Clofazimine—Rash—Captopril—systemic scleroderma	0.000825	0.00258	CcSEcCtD
Clofazimine—Dermatitis—Captopril—systemic scleroderma	0.000825	0.00258	CcSEcCtD
Clofazimine—Somnolence—Lisinopril—systemic scleroderma	0.000824	0.00258	CcSEcCtD
Clofazimine—Headache—Captopril—systemic scleroderma	0.00082	0.00257	CcSEcCtD
Clofazimine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000814	0.00255	CcSEcCtD
Clofazimine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000812	0.00254	CcSEcCtD
Clofazimine—Decreased appetite—Lisinopril—systemic scleroderma	0.000806	0.00252	CcSEcCtD
Clofazimine—Eosinophilia—Methotrexate—systemic scleroderma	0.000801	0.00251	CcSEcCtD
Clofazimine—Fatigue—Lisinopril—systemic scleroderma	0.000799	0.0025	CcSEcCtD
Clofazimine—Constipation—Lisinopril—systemic scleroderma	0.000793	0.00248	CcSEcCtD
Clofazimine—Diarrhoea—Azathioprine—systemic scleroderma	0.000782	0.00245	CcSEcCtD
Clofazimine—Nausea—Captopril—systemic scleroderma	0.000778	0.00243	CcSEcCtD
Clofazimine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000774	0.00242	CcSEcCtD
Clofazimine—Asthenia—Leflunomide—systemic scleroderma	0.000774	0.00242	CcSEcCtD
Clofazimine—Pruritus—Leflunomide—systemic scleroderma	0.000763	0.00239	CcSEcCtD
Clofazimine—Dizziness—Azathioprine—systemic scleroderma	0.000756	0.00236	CcSEcCtD
Clofazimine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000739	0.00231	CcSEcCtD
Clofazimine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000739	0.00231	CcSEcCtD
Clofazimine—Diarrhoea—Leflunomide—systemic scleroderma	0.000738	0.00231	CcSEcCtD
Clofazimine—Body temperature increased—Lisinopril—systemic scleroderma	0.000733	0.00229	CcSEcCtD
Clofazimine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000728	0.00228	CcSEcCtD
Clofazimine—Vomiting—Azathioprine—systemic scleroderma	0.000726	0.00227	CcSEcCtD
Clofazimine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000722	0.00226	CcSEcCtD
Clofazimine—Drowsiness—Methotrexate—systemic scleroderma	0.000722	0.00226	CcSEcCtD
Clofazimine—Rash—Azathioprine—systemic scleroderma	0.00072	0.00225	CcSEcCtD
Clofazimine—Dermatitis—Azathioprine—systemic scleroderma	0.00072	0.00225	CcSEcCtD
Clofazimine—Depression—Methotrexate—systemic scleroderma	0.000719	0.00225	CcSEcCtD
Clofazimine—Headache—Azathioprine—systemic scleroderma	0.000716	0.00224	CcSEcCtD
Clofazimine—Dizziness—Leflunomide—systemic scleroderma	0.000714	0.00223	CcSEcCtD
Clofazimine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000706	0.00221	CcSEcCtD
Clofazimine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000704	0.0022	CcSEcCtD
Clofazimine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000695	0.00217	CcSEcCtD
Clofazimine—Vomiting—Leflunomide—systemic scleroderma	0.000686	0.00215	CcSEcCtD
Clofazimine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000681	0.00213	CcSEcCtD
Clofazimine—Rash—Leflunomide—systemic scleroderma	0.00068	0.00213	CcSEcCtD
Clofazimine—Dermatitis—Leflunomide—systemic scleroderma	0.00068	0.00213	CcSEcCtD
Clofazimine—Nausea—Azathioprine—systemic scleroderma	0.000679	0.00212	CcSEcCtD
Clofazimine—Headache—Leflunomide—systemic scleroderma	0.000676	0.00211	CcSEcCtD
Clofazimine—Asthenia—Lisinopril—systemic scleroderma	0.000665	0.00208	CcSEcCtD
Clofazimine—Pruritus—Lisinopril—systemic scleroderma	0.000656	0.00205	CcSEcCtD
Clofazimine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000654	0.00205	CcSEcCtD
Clofazimine—Rash—Mycophenolic acid—systemic scleroderma	0.000649	0.00203	CcSEcCtD
Clofazimine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000648	0.00203	CcSEcCtD
Clofazimine—Hepatitis—Methotrexate—systemic scleroderma	0.000648	0.00203	CcSEcCtD
Clofazimine—Headache—Mycophenolic acid—systemic scleroderma	0.000645	0.00202	CcSEcCtD
Clofazimine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000642	0.00201	CcSEcCtD
Clofazimine—Nausea—Leflunomide—systemic scleroderma	0.000641	0.00201	CcSEcCtD
Clofazimine—Diarrhoea—Lisinopril—systemic scleroderma	0.000634	0.00198	CcSEcCtD
Clofazimine—Visual impairment—Methotrexate—systemic scleroderma	0.000624	0.00195	CcSEcCtD
Clofazimine—Anaemia—Prednisone—systemic scleroderma	0.000624	0.00195	CcSEcCtD
Clofazimine—Dizziness—Lisinopril—systemic scleroderma	0.000613	0.00192	CcSEcCtD
Clofazimine—Nausea—Mycophenolic acid—systemic scleroderma	0.000611	0.00191	CcSEcCtD
Clofazimine—Vomiting—Lisinopril—systemic scleroderma	0.00059	0.00184	CcSEcCtD
Clofazimine—Rash—Lisinopril—systemic scleroderma	0.000585	0.00183	CcSEcCtD
Clofazimine—Dermatitis—Lisinopril—systemic scleroderma	0.000584	0.00183	CcSEcCtD
Clofazimine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000583	0.00182	CcSEcCtD
Clofazimine—Headache—Lisinopril—systemic scleroderma	0.000581	0.00182	CcSEcCtD
Clofazimine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000575	0.0018	CcSEcCtD
Clofazimine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000556	0.00174	CcSEcCtD
Clofazimine—Nausea—Lisinopril—systemic scleroderma	0.000551	0.00172	CcSEcCtD
Clofazimine—Oedema—Prednisone—systemic scleroderma	0.000551	0.00172	CcSEcCtD
Clofazimine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000537	0.00168	CcSEcCtD
Clofazimine—Anorexia—Prednisone—systemic scleroderma	0.000525	0.00164	CcSEcCtD
Clofazimine—Anaemia—Methotrexate—systemic scleroderma	0.000521	0.00163	CcSEcCtD
Clofazimine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000517	0.00162	CcSEcCtD
Clofazimine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000512	0.0016	CcSEcCtD
Clofazimine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000512	0.0016	CcSEcCtD
Clofazimine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000509	0.00159	CcSEcCtD
Clofazimine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000483	0.00151	CcSEcCtD
Clofazimine—Decreased appetite—Prednisone—systemic scleroderma	0.000479	0.0015	CcSEcCtD
Clofazimine—Fatigue—Prednisone—systemic scleroderma	0.000475	0.00149	CcSEcCtD
Clofazimine—Constipation—Prednisone—systemic scleroderma	0.000471	0.00147	CcSEcCtD
Clofazimine—Anorexia—Methotrexate—systemic scleroderma	0.000439	0.00137	CcSEcCtD
Clofazimine—Body temperature increased—Prednisone—systemic scleroderma	0.000435	0.00136	CcSEcCtD
Clofazimine—Somnolence—Methotrexate—systemic scleroderma	0.000409	0.00128	CcSEcCtD
Clofazimine—Decreased appetite—Methotrexate—systemic scleroderma	0.0004	0.00125	CcSEcCtD
Clofazimine—Fatigue—Methotrexate—systemic scleroderma	0.000397	0.00124	CcSEcCtD
Clofazimine—Asthenia—Prednisone—systemic scleroderma	0.000395	0.00124	CcSEcCtD
Clofazimine—Pruritus—Prednisone—systemic scleroderma	0.00039	0.00122	CcSEcCtD
Clofazimine—Diarrhoea—Prednisone—systemic scleroderma	0.000377	0.00118	CcSEcCtD
Clofazimine—Dizziness—Prednisone—systemic scleroderma	0.000364	0.00114	CcSEcCtD
Clofazimine—Body temperature increased—Methotrexate—systemic scleroderma	0.000364	0.00114	CcSEcCtD
Clofazimine—Vomiting—Prednisone—systemic scleroderma	0.00035	0.0011	CcSEcCtD
Clofazimine—Rash—Prednisone—systemic scleroderma	0.000347	0.00109	CcSEcCtD
Clofazimine—Dermatitis—Prednisone—systemic scleroderma	0.000347	0.00109	CcSEcCtD
Clofazimine—Headache—Prednisone—systemic scleroderma	0.000345	0.00108	CcSEcCtD
Clofazimine—Asthenia—Methotrexate—systemic scleroderma	0.00033	0.00103	CcSEcCtD
Clofazimine—Nausea—Prednisone—systemic scleroderma	0.000327	0.00102	CcSEcCtD
Clofazimine—Pruritus—Methotrexate—systemic scleroderma	0.000326	0.00102	CcSEcCtD
Clofazimine—Diarrhoea—Methotrexate—systemic scleroderma	0.000315	0.000985	CcSEcCtD
Clofazimine—Dizziness—Methotrexate—systemic scleroderma	0.000304	0.000952	CcSEcCtD
Clofazimine—Vomiting—Methotrexate—systemic scleroderma	0.000293	0.000915	CcSEcCtD
Clofazimine—Rash—Methotrexate—systemic scleroderma	0.00029	0.000908	CcSEcCtD
Clofazimine—Dermatitis—Methotrexate—systemic scleroderma	0.00029	0.000907	CcSEcCtD
Clofazimine—Headache—Methotrexate—systemic scleroderma	0.000288	0.000902	CcSEcCtD
Clofazimine—Nausea—Methotrexate—systemic scleroderma	0.000273	0.000855	CcSEcCtD
